Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis-Reference-Cited by-同舟云学术

Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis

Published:2021-03-25 Issue:2 Volume:18 Page:938-948
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Ruetsch-Chelli Caroline^ORCID,Bresch Saskia,Seitz-Polski Barbara,Rosenthal Alessandra,Desnuelle Claude,Cohen Mikael,Brglez Vesna,Ticchioni Michel,Lebrun-Frenay Christine

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-021-01006-9.pdf

Reference32 articles.

1. Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30.

2. Dalakas MC. Immunotherapy in myasthenia gravis in the era of biologics. Nat Rev Neurol. 2019;15:113-24.

3. Jing S, Song Y, Song J, Pang S, Quan C, Zhou L, et al. Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis. J Neuroimmunol. 2017;311:14-21.

4. Afanasiev V, Demeret S, Bolgert F, Eymard B, Laforêt P, Benveniste O. Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients. Neuromuscul Disord. 2017;27:251-8.

5. Jing S, Lu J, Song J, Luo S, Zhou L, Quan C, et al. Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis. J Neuroimmunol. 2019;332:216-23.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis;Journal of Neurology;2024-06-05

2. Dental Adverse Effects of Anti-CD20 Therapies;Neurology and Therapy;2024-04-26

3. B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis;Frontiers in Immunology;2024-04-22

4. Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment;European Journal of Neurology;2024-02-06

5. Immune monitoring of patients treated with anti-CD20 therapeutic monoclonals for autoimmune disorders;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024